Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Another Reason Biopharma Insider Trading Is A Dumb Idea

This article was originally published in Scrip

Executive Summary

Two tax and estate planning lawyers and an accountant, plus two other men, have learned the hard way crime doesn't pay, especially when trying to trade on inside information involving biopharmaceutical firms – a sector the Securities and Exchange Commission (SEC) has been keeping a particularly close eye on in recent years.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register